Health Sector Priority Setting: QALYs, trials, and judgements Meeting report 10 February 2013 Pages: 3 - 4
Asthma severity underestimated, treatment suboptimal in the US Clinical study 10 February 2013 Pages: 5 - 5
Laboratory reporting influences antibacterial prescribing in the UK Clinical study 10 February 2013 Pages: 6 - 6
Cost analysis of modest interventions to prevent type 2 diabetes News item 10 February 2013 Pages: 7 - 7
Improvements needed to reduce resource use in ambulatory care-sensitive conditions Clinical study 10 February 2013 Pages: 7 - 7
Lidocaine needle-free jet-injection system value for money? Clinical study 10 February 2013 Pages: 7 - 7
Comorbidities in parkinsonism lead to high resource use, costs Clinical study 10 February 2013 Pages: 8 - 8
PEG IFN-α-2b plus ribavirin worth its cost in chronic hepatitis C Clinical study 10 February 2013 Pages: 8 - 8
Opioid analgesics underused for neuropathic pain in Canada Clinical study 10 February 2013 Pages: 9 - 9
Low-dose HRT improves symptoms, QOL in postmenopausal women Clinical study 10 February 2013 Pages: 10 - 10
NZ Pharmac welcomes GSK's fluticasone propionate decision Media release 10 February 2013 Pages: 11 - 11
TB drug facility expands coverage to nearly 2 million patients News item 10 February 2013 Pages: 11 - 11
Concern over diabetes coverage proposed under US Medicaid reforms Media release 10 February 2013 Pages: 12 - 12